Literature DB >> 15910639

Successful treatment of Type B insulin resistance in a patient with otherwise quiescent systemic lupus erythematosus.

A P Coll, D Morganstein, D Jayne, M A Soos, S O'Rahilly, J Burke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15910639     DOI： 10.1111/j.1464-5491.2005.01529.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN： 0742-3071            Impact factor:   4.359


× No keyword cloud information.
  8 in total

1.  Treatment of type B insulin resistance: a novel approach to reduce insulin receptor autoantibodies.

Authors:  R Malek; A Y Chong; B C Lupsa; A O Lungu; E K Cochran; M A Soos; R K Semple; J E Balow; P Gorden
Journal:  J Clin Endocrinol Metab       Date:  2010-05-19       Impact factor: 5.958

Review 2.  Type B insulin resistance syndrome induced by systemic lupus erythematosus and successfully treated with intravenous immunoglobulin: case report and systematic review.

Authors:  Sigong Zhang; Guochun Wang; Jinping Wang
Journal:  Clin Rheumatol       Date:  2012-10-03       Impact factor: 2.980

Review 3.  Syndromic insulin resistance: models for the therapeutic basis of the metabolic syndrome and other targets of insulin resistance.

Authors:  Phillip Gorden; Elika Safar Zadeh; Elaine Cochran; Rebecca J Brown
Journal:  Endocr Pract       Date:  2012 Sep-Oct       Impact factor: 3.443

4.  A case of systemic lupus erythematosus presenting as hypoglycemia due to anti-insulin receptor antibodies.

Authors:  Yuuka Kato; Yoshiro Ichiki; Yasuo Kitajima
Journal:  Rheumatol Int       Date:  2008-05-24       Impact factor: 2.631

5.  Paradoxical elevation of high-molecular weight adiponectin in acquired extreme insulin resistance due to insulin receptor antibodies.

Authors:  Robert K Semple; Nils H Halberg; Keith Burling; Maria A Soos; Todd Schraw; Jian'an Luan; Elaine K Cochran; David B Dunger; Nicholas J Wareham; Philipp E Scherer; Phillip Gorden; Stephen O'Rahilly
Journal:  Diabetes       Date:  2007-02-26       Impact factor: 9.461

6.  SEVERE INSULIN RESISTANCE WITH DIABETIC KETOACIDOSIS AFTER BRENTUXIMAB TREATMENT.

Authors:  Janet M Chiang; Andrew R Lai; Mark Anderson; Robert J Rushakoff
Journal:  AACE Clin Case Rep       Date:  2020-01-22

7.  Insulin resistance uncoupled from dyslipidemia due to C-terminal PIK3R1 mutations.

Authors:  Isabel Huang-Doran; Patsy Tomlinson; Felicity Payne; Alexandra Gast; Alison Sleigh; William Bottomley; Julie Harris; Allan Daly; Nuno Rocha; Simon Rudge; Jonathan Clark; Albert Kwok; Stefano Romeo; Emma McCann; Barbara Müksch; Mehul Dattani; Stefano Zucchini; Michael Wakelam; Lazaros C Foukas; David B Savage; Rinki Murphy; Stephen O'Rahilly; Inês Barroso; Robert K Semple
Journal:  JCI Insight       Date:  2016-10-20

8.  Type B Insulin Resistance Masquerading as Ovarian Hyperthecosis.

Authors:  Rebecca J Brown; Jalaja Joseph; Elaine Cochran; Cornelia Gewert; Robert Semple; Phillip Gorden
Journal:  J Clin Endocrinol Metab       Date:  2017-06-01       Impact factor: 5.958
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.